CAP1 and metabolic syndrome: Resistin, an important adipokine, upregulates fatty acid oxidation (FAO) in synovial cells via the CAP1/PKA/CREB signaling pathway, thereby promoting inflammation and a catabolic phenotype that further exacerbates the progression of metabolic syndrome-related knee OA (MetS-KOA) (54).